| 发明名称 | Fusion protein of human fibroblast growth factor-21 and exendin-4 | ||
| 摘要 | Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc. | ||
| 申请公布号 | US8809499(B2) | 申请公布日期 | 2014.08.19 |
| 申请号 | US201013391226 | 申请日期 | 2010.03.12 |
| 申请人 | Chongqing Fagen Biomedical Inc. | 发明人 | Fan Kai;Zhao Zhiquan;Zhang Chun;Chen Yong;Luo Hua;Yang Li;Liu Honghong |
| 分类号 | C07K14/50;C12N1/21;C12N15/12;C12N15/63;C07K14/605;C07K14/43;A61K38/00 | 主分类号 | C07K14/50 |
| 代理机构 | Maschoff Brennan | 代理人 | Maschoff Brennan |
| 主权项 | 1. A fusion protein having a formula of R2-R1 or R2-L-R1, wherein: R1 is a human fibroblast growth factor 21; R2 is Exendin-4; and L is a linker. | ||
| 地址 | Chongqing CN | ||